Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

7

Revenue 2017

Prevnar 13

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prevnar 13 was produced by Pfizer.

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Patients receiving Merck and Eisai’s treatment had a complete response rate of 5% compared with 3% for doxorubicin or paclitaxel, and a partial response rate of 25% versus 13% respectively.

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat The FDA’s cardiovascular and renal drugs advisory committee (CRDAC) has voted 13 to one that the benefit-risk profile of roxadustat does not support approval for the treatment of anaemia

AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues

AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues body. There have been 100 reports of the syndrome in people who have received the J&J vaccine, out of nearly 13 million individuals in the US who have received the

FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine

FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine vaccine, out of nearly 13 million individuals in the US who have received the jab.

WHO recommends ‘life-saving’ IL-6 inhibitors for severe COVID-19

WHO recommends ‘life-saving’ IL-6 inhibitors for severe COVID-19 According to WHO’s meta-analyses, when Kevzara or Actemra are administered to severely ill or critically ill COVID-19 patients, these drugs can reduce the risk of death by 13%

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....